Brain Scientific Inc. (BRSF) Receives FDA Clearance for Next-Gen NeuroCap
BRSF announced it has FDA clearance for next-gen NeuroCap The newest version of the NeuroCap has added velcro strips, expanded size range to include pediatrics New device can stay on the patient’s head for up to four hours Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, announced it has received clearance from the FDA for its next-generation NeuroCap(TM) (https://ibn.fm/RYmMH). This device is an advanced electroencephalogram (“EEG”) electrode array used in routine clinical and research settings. Like the previous version, the newest version of the NeuroCap will help improve patient access to neurological care through its simplicity, cost efficiency and one-time…